Bonita David P's Form 4 filing
Third Harmonic Bio, Inc.THRD · filed Sep 21, 2022
- Accession no.
- 0001209191-22-050937
- Filed
- Sep 21, 2022
- Trade date
- Sep 19, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market purchases total $5.10M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bonita David PCIK 0001572451 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2022 | Common Stock | CConversionAcquired | +5,479,071 | –F1 | – | 5,479,071 | Indirect | |
| Sep 19, 2022 | Common Stock | PPurchaseAcquired | +300,000 | $17.00 | +$5,100,000 | 5,779,071 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2022 | Common Stock | CConversionDisposed | −3,804,228 | –F1 | – | 0 | Indirect | |
| Sep 19, 2022 | Common Stock | CConversionDisposed | −1,080,747 | –F1 | – | 0 | Indirect | |
| Sep 19, 2022 | Common Stock | CConversionDisposed | −594,096 | –F1 | – | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each share of the Issuer's Series A-2 Preferred Stock, Series A-3 Preferred Stock, and Series B Preferred Stock automatically converted into the number of shares of the Issuer's Common Stock based on a 1 to 2.259 reverse stock conversion ratio immediately prior to the closing of the Issuer's initial public offering and has no expiration date.
Referenced by the price of 1 transaction in Table I and 3 transactions in Table II.